{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T22:06:51Z","timestamp":1792534011613,"version":"4.5.0"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.ejogrb.2019.04.016","type":"journal-article","created":{"date-parts":[[2019,4,17]],"date-time":"2019-04-17T09:22:31Z","timestamp":1555492951000},"page":"89-92","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Prevalence and obstetric outcome of women with red cell antibodies in pregnancy at the Leeds Teaching Hospitals NHS Trust, West Yorkshire, England"],"prefix":"10.1016","volume":"237","author":[{"given":"Ibraheem","family":"Awowole","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Rock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colette","family":"Sparey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2019.04.016_bib0005","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1111\/j.0041-1132.2003.00632.x","article-title":"Thirty-five years of Rh prophylaxis","volume":"43","author":"Bowman","year":"2003","journal-title":"Transfusion"},{"key":"10.1016\/j.ejogrb.2019.04.016_bib0010","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/tme.12091","article-title":"BCSH guideline for the use of anti-D immunoglobulin for the prevention of haemolytic disease of the fetus and newborn","author":"Qureshi","year":"2014","journal-title":"Transfus Med"},{"issue":"1","key":"10.1016\/j.ejogrb.2019.04.016_bib0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2249.2008.03735.x","article-title":"Lessons learnt from many years of experience using anti-D in humans for prevention of RhD immunization and haemolytic disease of the fetus and newborn","volume":"154","author":"Kumpel","year":"2008","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.ejogrb.2019.04.016_bib0020","series-title":"The management of women with red cell antibodies during pregnancy","author":"Royal College of Obstetricians and Gynaecologists","year":"2014"},{"issue":"1","key":"10.1016\/j.ejogrb.2019.04.016_bib0025","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1046\/j.1365-3148.1999.009001099.x","article-title":"Addendum for guidelines for blood grouping and red cell antibody testing during pregnancy","volume":"9","author":"Chapman","year":"1999","journal-title":"Transfusion Med"},{"key":"10.1016\/j.ejogrb.2019.04.016_bib0030","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/tme.12299","article-title":"Guideline for blood grouping and red cell antibody testing in pregnancy","volume":"26","author":"White","year":"2016","journal-title":"Transfus Med"},{"key":"10.1016\/j.ejogrb.2019.04.016_bib0035","doi-asserted-by":"crossref","first-page":"F62","DOI":"10.1136\/fn.78.1.F62","article-title":"Consequences for fetus and neonate of maternal red cell allo-immunisation","volume":"78","author":"Howard","year":"1998","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"9","key":"10.1016\/j.ejogrb.2019.04.016_bib0040","doi-asserted-by":"crossref","first-page":"687","DOI":"10.3109\/00016349509021175","article-title":"The prevalence of red cell antibodies in pregnancy correlated to the outcome of the newborn: a 12 year study in central Sweden","volume":"74","author":"Filbey","year":"1995","journal-title":"Acta Obstet Gynecol Scand Suppl"},{"key":"10.1016\/j.ejogrb.2019.04.016_bib0045","series-title":"Routine antenatal anti-D prophylaxis for women who are rhesus D negative","author":"National Institute for Health and Care Excellence","year":"2008"},{"key":"10.1016\/j.ejogrb.2019.04.016_bib0050","series-title":"Full guidance on the use of routine antenatal anti-D prophylaxis for Rh D negative women","author":"National Institute for Health and Clinical Excellence","year":"2002"},{"key":"10.1016\/j.ejogrb.2019.04.016_bib0055","series-title":"NIHR health technology assessment","article-title":"Routine antenatal anti-D prophylaxis for RhD-negative women: a systematic review and economic evaluation","author":"Pilgrim","year":"2009"},{"issue":"10","key":"10.1016\/j.ejogrb.2019.04.016_bib0060","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1111\/j.1537-2995.2009.02233.x","article-title":"Red blood cell antibodies in pregnancy and their clinical consequences: synergistic effects of multiple specificities","volume":"49","author":"Nordvall","year":"2009","journal-title":"Transfusion"},{"key":"10.1016\/j.ejogrb.2019.04.016_bib0065","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJM200001063420102","article-title":"Noninvasive Diagnosis by Doppler Ultrasonography of Fetal Anemia Due to Maternal Red-Cell Alloimmunization","volume":"342","author":"Mari","year":"2000","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.ejogrb.2019.04.016_bib0070","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1111\/j.1471-0528.1991.tb13511.x","article-title":"Fetal blood sampling and pregnancy loss in relation to indication","volume":"98","author":"Maxwell","year":"1991","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.ejogrb.2019.04.016_bib0075","series-title":"MBRRACE-UK perinatal mortality surveillance report, UK perinatal deaths for births from January to December 2016","author":"Draper","year":"2018"},{"key":"10.1016\/j.ejogrb.2019.04.016_bib0080","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1111\/1471-0528.13055","article-title":"Use of cffDNA to avoid administration of anti-D to pregnant women when the fetus is RhD-negative: implementation in the NHS","volume":"122","author":"Soothill","year":"2015","journal-title":"Brit J Obstet Gynaecol."},{"key":"10.1016\/j.ejogrb.2019.04.016_bib0085","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/1471-2393-14-87","article-title":"Routine administration of Anti-D: the ethical case for offering pregnant women fetal RHD genotyping and a review of policy and practice","volume":"14","author":"Kent","year":"2014","journal-title":"BMC Pregnancy Childbirth"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211519301800?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211519301800?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T05:45:31Z","timestamp":1759556731000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211519301800"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":17,"alternative-id":["S0301211519301800"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2019.04.016","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence and obstetric outcome of women with red cell antibodies in pregnancy at the Leeds Teaching Hospitals NHS Trust, West Yorkshire, England","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2019.04.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}